genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
Authors
Posts by MaryAnn Labant
MaryAnn Labant
OMICs
Enzymatic DNA Synthesis: Shorter Waits, Longer Strands
Bioprocessing
Upstream Bioprocessing: Virtual Bioreactors Get Real
Bioprocessing
Cell Therapy Manufacturing: Time to Move Fast
Translational Medicine
Platform Processes May Reduce AAV Gene Therapy Costs
Drug Discovery
Bioconjugates Meet and Promise to Exceed Expectations
Bioprocessing
Biomanufacturing’s Green Theme
Bioprocessing
Smart Biomanufacturing: From Piecemeal to All of a Piece
Bioprocessing
Cell Therapy Industry Looks for Ways to Sustain Growth
OMICs
NGS Sample Prep: Enduring Basics and Evolving Enzyme Kits
Bioprocessing
Forwarding Allogeneic Therapies
1
2
3
…
11
>
Page 1 of 11
Scroll Up
